Publications by authors named "Robert Mahn"

Claim this Profile
L
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures.
Maria A Gonzalez-Carmona, Alina M Schmitz, Moritz Berger, Leona I Baier, Jens G Gorny, Robert Mahn

Int J Mol Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma.
Michael Praktiknjo, Ana S Pena Solano, Farsaneh Sadeghlar, Thomas Welchowski, Matthias Schmid, Robert Mahn

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison.
Robert Mahn, Oscar André Glüer, Farsaneh Sadeghlar, Christian Möhring, Taotao Zhou

J Hepatocell Carcinoma· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
Farsaneh Sadeghlar, Julia Seelemann, Annabelle Vogt, Christian Möhring, Taotao Zhou, Robert Mahn

Immunol Invest· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients.
Malte B Monin, Leona I Baier, Jens G Gorny, Moritz Berger, Taotao Zhou, Robert Mahn

Liver Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real-world cohort.
Christian Möhring, Adrianna Mańczak, Aliki Timotheou, Farsaneh Sadeghlar, Taotao Zhou, Robert Mahn

Int J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
Christian Möhring, Oliver Khan, Taotao Zhou, Farsaneh Sadeghlar, Robert Mahn

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination.
Malte Benedikt Monin, Leona Baier, Moritz Berger, Jens Gabriel Gorny, Taotao Zhou, Robert Mahn

Gut· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired immunogenicity after vaccination for SARS-CoV-2 in patients with gastrointestinal cancer: does tumor entity matter?
Malte Benedikt Monin, Jens Gabriel Gorny, Moritz Berger, Leona I Baier, Taotao Zhou, Robert Mahn

J Gastrointest Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
Christian Möhring, Aliki Timotheou, Adrianna Mańczak, Farsaneh Sadeghlar, Taotao Zhou, Robert Mahn

J Cancer Res Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature.
Christian Möhring, Freddy José Frontado Graffe, Alexandra Bartels, Farsaneh Sadeghlar, Taotao Zhou, Robert Mahn

J Gastrointest Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate.
Taotao Zhou, Robert Mahn, Christian Möhring, Farsaneh Sadeghlar, Carsten Meyer

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
Maria A Gonzalez-Carmona, Christian Möhring, Robert Mahn, Taotao Zhou, Alexandra Bartels

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis.
Christian Möhring, Jan Feder, Raphael U Mohr, Farsaneh Sadeghlar, Alexandra Bartels, Robert Mahn

Front Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomes.
Robert Mahn, Farsaneh Sadeghlar, Alexandra Bartels, Taotao Zhou, Tobias Weismüller

Medicine (Baltimore)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
Annabelle Vogt, Farsaneh Sadeghlar, Tiyasha H Ayub, Carlo Schneider, Christian Möhring, Robert Mahn

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Farsaneh Sadeghlar, Annabelle Vogt, Raphael U Mohr, Robert Mahn, Katrin van Beekum

Cancer Immunol Immunother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience.
Robert Mahn, Annabelle Vogt, Patrick Kupczyk, Farsaneh Sadeghlar, Katrin van Beekum

Scand J Gastroenterol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma.
Maria Angeles Gonzalez-Carmona, Maximilian Bolch, Christian Jansen, Annabelle Vogt, Matthias Sampels, Robert Mahn

Aliment Pharmacol Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
Robert Mahn, Lukas C Heukamp, Sebastian Rogenhofer, Alexander von Ruecker, Stefan C Müller

Urology· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis